Other targeted therapies interrupt the signals that cause lung cancer cells to multiply, as shown in the highly magnified image here.

Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.

KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.